The postpartum cardiovascular risk factor profile of women with isolated hyperglycemia at 1-hour on the oral glucose tolerance test in pregnancy

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 21, Issue 9, 2011, Pages 706-712

  Retnakaran, R ^a,b   Qi, Y ^a   Sermer, M ^c   Connelly, P W ^b,d   Hanley, A J ^a,b   Zinman, B ^a,b  

^a Leadership Sinai Centre for Diabetes   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c Pediatric Oral and Maxillofacial Surgery   (Canada)

^d ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

C Reactive protein; Cardiovascular risk factors; Gestational diabetes; Gestational impaired glucose tolerance; Postpartum

Indexed keywords

APOLIPOPROTEIN B; C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LEPTIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; BLOOD; CARDIOVASCULAR DISEASE; FEMALE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HUMAN; HYPERGLYCEMIA; METABOLISM; PATHOPHYSIOLOGY; PREGNANCY; PREGNANCY DIABETES MELLITUS; PROSPECTIVE STUDY; PUERPERIUM; RISK FACTOR;

ADULT; APOLIPOPROTEINS B; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DIABETES, GESTATIONAL; FEMALE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HUMANS; HYPERGLYCEMIA; LEPTIN; POSTPARTUM PERIOD; PREGNANCY; PROSPECTIVE STUDIES; RISK FACTORS;

EID: 80052729882     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2011.02.010     Document Type: Article

References (32)

1. Retnakaran R., Qi Y., Sermer M., Connelly P.W., Hanley A.J., Zinman B. Glucose intolerance in pregnancy and future risk of pre-diabetes or diabetes. Diabetes Care 2008, 31:2026-2031.
2. Retnakaran R., Shah B. Abnormal screening glucose challenge test in pregnancy and future risk of diabetes in young women. Diabet Med 2009, 26(5):474-477.
3. Retnakaran R., Zinman B., Connelly P.W., Sermer M., Hanley A.J. Impaired glucose tolerance of pregnancy is a heterogeneous metabolic disorder as defined by the glycemic response to the oral glucose tolerance test. Diabetes Care 2006, 29:57-62.
4. Di Cianni G., Seghieri G., Lencioni C., Cuccuru I., Anichini R., De Bellis A., et al. Normal glucose tolerance and gestational diabetes mellitus: what is in between?. Diabetes Care 2007, 30(7):1783-1788.
5. Corrado F., Benedetto A.D., Cannata M.L., Cannizzaro D., Giordano D., Indorato G., et al. A single abnormal value of the glucose tolerance test is related to increased adverse perinatal outcome. J Matern Fetal Neonatal Med 2009, 22(7):597-601.
6. Miyakoshi K., Tanaka M., Saisho Y., Shimada A., Minegishi K., Kim S.H., et al. Pancreatic beta-cell function and fetal growth in gestational impaired glucose tolerance. Acta Obstet Gynecol Scand 2010, 89(6):769-775.
7. Retnakaran R., Qi Y., Sermer M., Connelly P.W., Zinman B., Hanley A.J. Isolated hyperglycemia at 1-hour on oral glucose tolerance test in pregnancy resembles gestational diabetes in predicting postpartum metabolic dysfunction. Diabetes Care 2008, 31:1275-1281.
8. Shah B.R., Retnakaran R., Booth G.L. Increased risk of cardiovascular disease in young women following gestational diabetes. Diabetes Care 2008, 31(8):1668-1669.
9. Retnakaran R., Shah B. Mild glucose intolerance in pregnancy and risk of cardiovascular disease in young women: population-based cohort study. Can Med Assoc J 2009, 181(6-7):371-376.
10. Retnakaran R., Qi Y., Connelly P.W., Sermer M., Hanley A.J., Zinman B. Glucose intolerance in pregnancy and postpartum risk of metabolic syndrome in young women. J Clin Endocrinol Metab 2010, 95:670-677.
11. Retnakaran R., Qi Y., Connelly P.W., Sermer M., Hanley A.J., Zinman B. Low adiponectin concentration during pregnancy predicts postpartum insulin resistance, beta-cell dysfunction and fasting glycaemia. Diabetologia 2010, 53:268-276.
12. Retnakaran R., Qi Y., Connelly P.W., Sermer M., Hanley A.J., Zinman B. The graded relationship between glucose tolerance status in pregnancy and postpartum levels of LDL cholesterol and apolipoprotein B in young women: implications for future cardiovascular risk. J Clin Endocrinol Metab 2010, 95(9):4345-4353.
13. Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 1979, 28:1039-1057. National Diabetes Data Group.
14. McQueen M.J., Hawken S., Wang X., Ounpuu S., Sniderman A., Probstfield J., et al. INTERHEART study investigators. Lipids, lipoproteins, and apolipoproteins as risk markers of myocardial infarction in 52 countries (the INTERHEART study): a case-control study. Lancet 2008, 372:224-233.
15. Carnevale Schianca G.P., Pedrazzoli R., Onolfo S., Colli E., Cornetti E., Bergamasco L., et al. Bartoli E.ApoB/apoA-I ratio is better than LDL-C in detecting cardiovascular risk. Nutr Metab Cardiovasc Dis 2010, Feb 18. [Epub ahead of print].
16. Schäfer-Graf U.M., Dupak J., Vogel M., Dudenhausen J.W., Kjos S.L., Buchanan T.A., et al. Hyperinsulinism, neonatal obesity and placental immaturity in infants born to women with one abnormal glucose tolerance test value. J Perinat Med 1998, 26(1):27-36.
17. Ergin T., Lembet A., Duran H., Kuscu E., Bagis T., Saygili E., et al. Does insulin secretion in patients with one abnormal glucose tolerance test value mimic gestational diabetes mellitus?. Am J Obstet Gynecol 2002, 186(2):204-209.
18. Kalamegham R., Nuwayhid B.S., Mulla Z.D. Prevalence of gestational fasting and postload single dysglycemia in Mexican-American women and their relative significance in identifying carbohydrate intolerance. Am J Perinatol 2010, 27(9):697-704.
19. Ingelsson E., Schaefer E.J., Contois J.H., McNamara J.R., Sullivan L., Keyes M.J., et al. Clinical utility of different lipid measures for prediction of coronary heart disease in men and women. JAMA 2007, 298(7):776-785.
20. Lewington S., Whitlock G., Clarke R., Sherliker P., Emberson J., Halsey J., et al. Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths. Lancet 2007, 370(9602):1829-1839. Prospective Studies Collaboration.
21. Sierra-Johnson J., Fisher R.M., Romero-Corral A., Somers V.K., Lopez-Jimenez F., Ohrvik J., et al. Concentration of apolipoprotein B is comparable with the apolipoprotein B/apolipoprotein A-I ratio and better than routine clinical lipid measurements in predicting coronary heart disease mortality: findings from a multi-ethnic US population. Eur Heart J 2009, 30(6):710-717.
22. Kaptoge S., Di Angelantonio E., Lowe G., Pepys M.B., Thompson S.G., et al. C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis. Lancet 2010, 375(9709):132-140. Emerging Risk Factors Collaboration.
23. C-reactive protein: eighty years from discovery to emergence as a major risk marker for cardiovascular disease. Clin Chem 2009, 55(2):209-215. Ridker PM.
24. Nordestgaard B.G., Zacho J. Lipids, atherosclerosis and CVD risk: is CRP an innocent bystander?. Nutr Metab Cardiovasc Dis 2009, 19(8):521-524.
25. Sattar N., Wannamethee G., Sarwar N., Chernova J., Lawlor D.A., Kelly A., et al. Leptin and coronary heart disease: prospective study and systematic review. J Am Coll Cardiol 2009, 53(2):167-175.
26. Paradisi G., Biaggi A., Ferrazzani S., De Carolis S., Caruso A. Abnormal carbohydrate metabolism during pregnancy: association with endothelial dysfunction. Diabetes Care 2002, 25:560-564.
27. Siervo M., Corander M., Stranges S. Bluck L.Post-challenge hyperglycaemia, nitric oxide production and endothelial dysfunction: the putative role of asymmetric dimethylarginine (ADMA). Nutr Metab Cardiovasc Dis 2010 Dec 13, [Epub ahead of print].
28. Kim H.S., Chang K.H., Yang J.I., Yang S.C., Lee H.J., Ryu H.S. Clinical outcomes of pregnancy with one elevated glucose tolerance test value. Int J Gynaecol Obstet 2002, 78(2):131-138.
29. Smith G.C., Pell J.P., Walsh D. Pregnancy complications and maternal risk of ischaemic heart disease: a retrospective cohort study of 129,290 births. Lancet 2001, 357(9273):2002-2006.
30. Ray J.G., Vermeulen M.J., Schull M.J., Redelmeier D.A. Cardiovascular health after maternal placental syndromes (CHAMPS): population-based retrospective cohort study. Lancet 2005, 366(9499):1797-1803.
31. Manuel D.G., Leung M., Nguyen K., Tanuseputro P., Johansen H. Canadian cardiovascular outcomes Research Team. Burden of cardiovascular disease in Canada. Can J Cardiol 2003, 19:997-1004.
32. Simpson F., Whitehead J.P. Adiponectin - it's all about the modifications. Int J Biochem Cell Biol 2010, 42(6):785-788.